Early versus Deferred Hormonal Treatment for Asymptomatic Prostate Cancer

Publisher： Karger

E-ISSN： 2296-5262|24|3|214-220

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.24, Iss.3, 2001-07, pp. : 214-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant Hormonal Treatment for Prostate Cancer: The Bicalutamide Early Prostate Cancer Program

By  

Oncology, Vol. 65, Iss. 1, 2003-09 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

Neoadjuvant Hormonal Treatment and Radiotherapy for Prostate Cancer

By  

Oncology, Vol. 65, Iss. 1, 2003-09 ,pp. : 29-33

Karger

Access to resources Recommend Favorite

Hormonal Predictors of Prostate Cancer

By  

Urologia Internationalis, Vol. 79, Iss. 1, 2007-07 ,pp. : 13-18

Karger

Access to resources Recommend Favorite

Comparative effectiveness of aggressive versus nonaggressive treatment among men with early‐stage prostate cancer and differing comorbid disease burdens at diagnosis

By  

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2432-2439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hormonal Therapy of Prostate Cancer: Is There Any News?

By  

Urologia Internationalis, Vol. 63, Iss. 1, 1999-12 ,pp. : 80-85

Karger

Access to resources Recommend Favorite